[go: up one dir, main page]

UA89383C2 - СПОСОБ ПРОИЗВОДСТВА СЛИТОГО БЕЛКА TNFR-Ig (ВАРИАНТЫ) - Google Patents

СПОСОБ ПРОИЗВОДСТВА СЛИТОГО БЕЛКА TNFR-Ig (ВАРИАНТЫ)

Info

Publication number
UA89383C2
UA89383C2 UAA200703287A UAA200703287A UA89383C2 UA 89383 C2 UA89383 C2 UA 89383C2 UA A200703287 A UAA200703287 A UA A200703287A UA A200703287 A UAA200703287 A UA A200703287A UA 89383 C2 UA89383 C2 UA 89383C2
Authority
UA
Ukraine
Prior art keywords
approximately
total amount
glutamine
amino acids
molar ratio
Prior art date
Application number
UAA200703287A
Other languages
English (en)
Ukrainian (uk)
Inventor
Дени Драпо
Йен-Тунг Луан
Джеймс Р. Мерсер
Венг ВАНГ
Дениэл Р. ЛЕСКО
Original Assignee
Уайет Ресерч Айрленд Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35500648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA89383(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Уайет Ресерч Айрленд Лимитед filed Critical Уайет Ресерч Айрленд Лимитед
Publication of UA89383C2 publication Critical patent/UA89383C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA200703287A 2004-08-27 2005-08-26 СПОСОБ ПРОИЗВОДСТВА СЛИТОГО БЕЛКА TNFR-Ig (ВАРИАНТЫ) UA89383C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60537904P 2004-08-27 2004-08-27

Publications (1)

Publication Number Publication Date
UA89383C2 true UA89383C2 (ru) 2010-01-25

Family

ID=35500648

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200703287A UA89383C2 (ru) 2004-08-27 2005-08-26 СПОСОБ ПРОИЗВОДСТВА СЛИТОГО БЕЛКА TNFR-Ig (ВАРИАНТЫ)

Country Status (38)

Country Link
US (1) US7300773B2 (ru)
EP (2) EP1781802B1 (ru)
JP (3) JP2008511330A (ru)
KR (1) KR100988451B1 (ru)
CN (2) CN101061231B (ru)
AR (2) AR050537A1 (ru)
AT (2) ATE461285T1 (ru)
AU (1) AU2005280036B2 (ru)
BR (1) BRPI0514694B8 (ru)
CA (1) CA2578138C (ru)
CL (1) CL2017000577A1 (ru)
CR (2) CR8998A (ru)
CY (2) CY1109721T1 (ru)
DE (2) DE602005017285D1 (ru)
DK (2) DK1781802T3 (ru)
EC (1) ECSP077354A (ru)
EG (1) EG26922A (ru)
ES (2) ES2341390T3 (ru)
GT (2) GT200500233A (ru)
HK (2) HK1121497A1 (ru)
HN (1) HN2005000485A (ru)
HR (2) HRP20100011T1 (ru)
IL (1) IL181588A (ru)
MX (1) MX2007002381A (ru)
MY (1) MY137803A (ru)
NO (1) NO344785B1 (ru)
NZ (1) NZ579208A (ru)
PE (2) PE20100448A1 (ru)
PL (2) PL1992697T3 (ru)
PT (2) PT1781802E (ru)
RS (2) RS51072B (ru)
RU (1) RU2458988C2 (ru)
SI (2) SI1992697T1 (ru)
SV (1) SV2006002211A (ru)
TW (1) TWI364458B (ru)
UA (1) UA89383C2 (ru)
WO (1) WO2006026447A2 (ru)
ZA (1) ZA200701672B (ru)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
EP3673919A1 (en) 2005-06-14 2020-07-01 Amgen Inc. Self-buffering protein formulations
PE20070796A1 (es) * 2005-10-24 2007-08-15 Wyeth Corp Metodo de produccion proteica utilizando compuestos anti-senescencia
US20070231895A1 (en) * 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
BRPI0714212B8 (pt) * 2006-07-13 2021-05-25 Wyeth Corp método de produzir uma glicoproteína em uma cultura celular
US8192951B2 (en) * 2006-11-03 2012-06-05 Wyeth Llc Glycolysis-inhibiting substances in cell culture
CN101535469A (zh) * 2006-11-08 2009-09-16 惠氏公司 合理设计的细胞培养基
MX2009009240A (es) 2007-03-02 2009-09-08 Wyeth Corp Uso de cobre y glutamato en el cultivo celular para la produccion de polipeptidos.
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
ES2624185T3 (es) 2007-04-26 2017-07-13 Chugai Seiyaku Kabushiki Kaisha Método de cultivo celular que utiliza un medio enriquecido con aminoácidos
KR101286895B1 (ko) * 2008-04-17 2013-07-16 와이어쓰 엘엘씨 골 형태발생 단백질의 개선된 생산 방법
WO2009127098A1 (zh) * 2008-04-18 2009-10-22 上海中信国健药业有限公司 一种浓缩培养液及其使用方法
EP2331700A2 (en) 2008-08-08 2011-06-15 Biogen Idec MA Inc. Nutrient monitoring and feedback control for increased bioproduct production
KR20180105258A (ko) 2009-08-11 2018-09-27 제넨테크, 인크. 글루타민-비함유 세포 배양 배지에서의 단백질의 생성
CN102770458A (zh) * 2009-12-02 2012-11-07 阿塞勒隆制药公司 用于增加Fc融合蛋白的血清半寿期的组合物和方法
JP6113653B2 (ja) 2010-04-26 2017-04-12 ノバルティス アーゲー 改良型細胞培養培地
LT3330370T (lt) 2010-04-26 2021-06-10 Novartis Ag Cho ląstelių auginimo būdas
US20130150554A1 (en) 2010-08-20 2013-06-13 Wyeth Llc Cell culture of growth factor-free adapted cells
AU2011329053A1 (en) * 2010-11-15 2013-06-06 Biogen Inc. Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
US9631216B2 (en) 2011-04-29 2017-04-25 Biocon Research Limited Method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof
US8883982B2 (en) 2011-06-08 2014-11-11 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life
AR088381A1 (es) 2011-10-18 2014-05-28 Coherus Biosciences Inc Formulaciones de etanercept estabilizadas con meglumina
US10485869B2 (en) 2011-10-18 2019-11-26 Coherus Biosciences, Inc. Etanercept formulations stabilized with meglumine
KR20170021919A (ko) 2011-10-21 2017-02-28 화이자 인코포레이티드 철을 첨가하여 세포 배양을 개선하는 방법
KR20140135766A (ko) * 2012-02-22 2014-11-26 엔브이아이피 피티와이 리미티드 종양괴사인자 수용체 융합 단백질 및 이를 이용하는 방법
EA029193B1 (ru) 2012-07-09 2018-02-28 Кохерус Байосайенсис, Инк. Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона
PE20200607A1 (es) 2012-09-11 2020-03-10 Coherus Biosciences Inc Etanercept correctamente plegado de alta pureza y excelente rendimiento
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
EP3391942A1 (en) 2013-03-26 2018-10-24 Coherus Biosciences, Inc. Protein production method
KR101439195B1 (ko) 2013-04-18 2014-09-12 동아대학교 산학협력단 에셰리키아 콜리 a-53 균주를 이용하여 섬유소 분해효소의 생산성을 향상시키는 공정
SG11201601681QA (en) * 2013-10-11 2016-04-28 Regeneron Pharma Metabolically optimized cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
AU2015210930B2 (en) * 2014-01-30 2020-04-30 Coherus Biosciences, Inc. Perfusion media
KR102382402B1 (ko) 2014-02-04 2022-04-01 바이오젠 엠에이 인코포레이티드 번역 후 변형을 강화시키기 위한 통류 방식 양이온 교환 크로마토그래피의 용도
CN107109455B (zh) 2014-12-01 2022-02-18 美国安进公司 用于操控糖蛋白的聚糖含量水平的方法
KR102007930B1 (ko) 2014-12-31 2019-08-06 주식회사 엘지화학 재조합 당단백질의 글리코실화 조절 방법
CN105777897A (zh) * 2015-03-20 2016-07-20 广东东阳光药业有限公司 一种cho细胞收获液的前处理方法
SG11201705743YA (en) * 2015-04-01 2017-08-30 Boehringer Ingelheim Int Cell culture medium
KR101936049B1 (ko) * 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
WO2018075818A1 (en) 2016-10-21 2018-04-26 Amgen Inc. Pharmaceutical formulations and methods of making the same
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN110484487A (zh) * 2019-08-21 2019-11-22 安徽欣乐生物技术有限公司 一种适用于cho细胞培养用无蛋白培养基及其培养方法
KR20230124578A (ko) 2020-12-22 2023-08-25 암젠 인크 세포 배양 방법
CN115073607A (zh) * 2021-03-12 2022-09-20 上海康岱生物医药技术股份有限公司 Tnfr2与baff受体的融合蛋白
CN114480492B (zh) * 2022-01-28 2023-04-21 景泽生物医药(合肥)股份有限公司 一种重组人抗体融合蛋白的制备方法

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DE68925971T2 (de) * 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
NZ235148A (en) 1989-09-05 1991-12-23 Immunex Corp Tumour necrosis factor receptor protein and dna sequences
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US5605690A (en) 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
JPH0396383A (ja) 1989-09-08 1991-04-22 Riso Kagaku Corp 画像形成装置
ATE236249T1 (de) 1989-09-12 2003-04-15 Hoffmann La Roche Tfn-bindende proteine
ES2118066T3 (es) 1989-10-05 1998-09-16 Optein Inc Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5538983A (en) 1990-05-16 1996-07-23 The Rockefeller University Method of treating amyloidosis by modulation of calcium
US5156964A (en) 1990-08-16 1992-10-20 Cetus Corporation Methods for adapting cells for increased product production through exposure to ammonia
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
GB9118664D0 (en) * 1991-08-30 1991-10-16 Celltech Ltd Cell culture
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
JP3504963B2 (ja) 1993-10-22 2004-03-08 智靖 羅 抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片
US6310185B1 (en) 1994-03-08 2001-10-30 Memorial Sloan Kettering Cancer Center Recombinant human anti-Lewis Y antibodies
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5589154A (en) 1994-11-22 1996-12-31 Rutgers, The State University Of New Jersey Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US5721121A (en) 1995-06-06 1998-02-24 Genentech, Inc. Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
US5705364A (en) 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6656466B1 (en) * 1995-06-06 2003-12-02 Genetech, Inc. Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
JP4306813B2 (ja) 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
CA2354862A1 (en) 1998-10-19 2000-04-27 Yeda Research And Development Co. Ltd. Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
PE20020574A1 (es) 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
DE60229051D1 (de) 2001-04-30 2008-11-06 Lilly Co Eli Humanisierte antikörper
ATE420114T1 (de) 2001-04-30 2009-01-15 Lilly Co Eli Humanisierte antikörper die das beta-amyloid peptid erkennen& x9;
US20030087372A1 (en) 2001-06-13 2003-05-08 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
MXPA04008150A (es) 2002-02-21 2005-06-17 Wyeth Corp Gasp1: una proteina que contiene dominio de folistatina.
CA2476654A1 (en) 2002-02-21 2003-09-04 Wyeth Follistatin domain containing proteins
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
EP1507556B1 (en) 2002-05-02 2016-07-27 Wyeth Holdings LLC Calicheamicin derivative-carrier conjugates
AR047392A1 (es) 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
US20040223966A1 (en) 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides

Also Published As

Publication number Publication date
MX2007002381A (es) 2007-06-15
SI1992697T1 (sl) 2010-07-30
US7300773B2 (en) 2007-11-27
MY137803A (en) 2009-03-31
EP1992697B1 (en) 2010-03-17
NO344785B1 (no) 2020-04-27
WO2006026447A2 (en) 2006-03-09
KR100988451B1 (ko) 2010-10-18
EP1781802A2 (en) 2007-05-09
EG26922A (en) 2014-12-25
RS51072B (sr) 2010-10-31
GT200500233A (es) 2006-03-09
GT200500234A (es) 2006-10-10
CN101061231A (zh) 2007-10-24
HK1099941A1 (en) 2007-08-31
HN2005000485A (es) 2009-06-09
EP1992697A1 (en) 2008-11-19
JP2008511330A (ja) 2008-04-17
CN102876761A (zh) 2013-01-16
KR20070069140A (ko) 2007-07-02
HRP20100011T1 (hr) 2010-02-28
SV2006002211A (es) 2006-10-04
PE20100448A1 (es) 2010-06-22
RS51255B (sr) 2010-12-31
WO2006026447A9 (en) 2006-06-01
JP5921910B2 (ja) 2016-05-24
BRPI0514694A (pt) 2008-06-17
TWI364458B (en) 2012-05-21
AR088824A2 (es) 2014-07-10
EP1781802B1 (en) 2009-10-21
HK1121497A1 (en) 2009-04-24
ES2335518T3 (es) 2010-03-29
ZA200701672B (en) 2012-04-24
CA2578138C (en) 2010-10-05
PT1992697E (pt) 2010-04-21
DE602005020076D1 (de) 2010-04-29
CA2578138A1 (en) 2006-03-09
TW200619388A (en) 2006-06-16
JP2012095672A (ja) 2012-05-24
PT1781802E (pt) 2010-01-04
DK1992697T3 (da) 2010-05-17
ES2341390T3 (es) 2010-06-18
CL2017000577A1 (es) 2017-12-01
HRP20100271T1 (hr) 2010-06-30
RU2007108717A (ru) 2008-10-10
CR8998A (es) 2007-11-23
DK1781802T3 (da) 2010-01-25
SI1781802T1 (sl) 2010-01-29
CR20120560A (es) 2012-12-04
JP2016056214A (ja) 2016-04-21
BRPI0514694B8 (pt) 2021-05-25
PL1992697T3 (pl) 2010-08-31
DE602005017285D1 (ru) 2009-12-03
ECSP077354A (es) 2007-05-30
CY1109721T1 (el) 2014-08-13
RU2458988C2 (ru) 2012-08-20
NZ579208A (en) 2012-01-12
AU2005280036B2 (en) 2011-11-03
IL181588A (en) 2010-12-30
ATE461285T1 (de) 2010-04-15
AR050537A1 (es) 2006-11-01
PL1781802T3 (pl) 2010-03-31
AU2005280036A1 (en) 2006-03-09
ATE446376T1 (de) 2009-11-15
PE20060815A1 (es) 2006-09-14
BRPI0514694B1 (pt) 2019-04-24
NO20071570L (no) 2007-05-23
CN101061231B (zh) 2012-09-26
US20060121569A1 (en) 2006-06-08
IL181588A0 (en) 2007-07-04
CY1110092T1 (el) 2015-01-14
WO2006026447A3 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
UA89383C2 (ru) СПОСОБ ПРОИЗВОДСТВА СЛИТОГО БЕЛКА TNFR-Ig (ВАРИАНТЫ)
UA89644C2 (ru) СПОСОБ ПРОИЗВОДСТВА α-АБЕТА (ВАРИАНТЫ)
SG158092A1 (en) Production of polypeptides
KR101644954B1 (ko) 배양 동안 락테이트의 축적을 감소시키는 방법 및 폴리펩타이드를 생산하는 방법
CN103597073B (zh) 低岩藻糖细胞系及其应用
NZ729633A (en) Targeted/immunomodulatory fusion proteins and methods for making same
JP6982578B2 (ja) 細胞培養培地
RU2712562C2 (ru) Модулирование клеточного роста и гликозилирования при производстве рекомбинантных гликопротеинов
CN107629124A (zh) 动物细胞的培养方法
AU2003303237A1 (en) Human monoclonal antibodies to epidermal growth factor receptor (egfr)
US10655156B2 (en) Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
MX2012003451A (es) Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para prepararlas.
JP5337043B2 (ja) 異種タンパク質を高生産する細胞の作製方法
ES2517603T3 (es) Procedimientos de producción recombinante de glucoproteínas
ZA200700343B (en) Plants having improved growth characteristics and method for making the same
JP6621744B2 (ja) 組換えタンパク質のグリコシル化を調節するためのモネンシンの使用
WO2008105432A1 (ja) アンモニア低発生性納豆菌、該納豆菌を用いた納豆の製造方法及び納豆
WO2010005227A3 (ko) 동물세포용 재조합 발현벡터
Song et al. Characterization and design of dipeptide media formulation for scalable therapeutic production
EP2971036B1 (en) Use of tricarboxylic acid (tca) intermediates to control ammonia generation in cell culture
TH115320A (th) การผลิต-ABeta
Bastami 5. ISLAMIC REPUBLIC OF IRAN
PH12012500523A1 (en) Plants having enhanced yield-related traits and a method for making the same
CN105624174A (zh) 一种促进丙酮酸分泌的基因、其提取方法和应用